Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Caerulomycin A suppresses the differentiation of naïve T cells and alleviates the symptoms of experimental autoimmune encephalomyelitis.

Autoimmunity - 1 Aug 2017

Kujur Weshely, Gurram Rama Krishna, Maurya Sudeep K, Nadeem Sajid, Chodisetti Sathi Babu, Khan Nargis, Agrewala Javed Naim

Abstract excerpt

Multiple sclerosis (MS) is a highly detrimental autoimmune disease of the central nervous system. There is no cure for it but the treatment typically focuses on subsiding severity and recurrence of the disease. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS. It is characterized by frequent relapses due to the generation of memory T cells. Caerulomycin A (CaeA) is known to suppress the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Encephalomyelitis, Autoimmune, Experimental
Share to Immunologic Memory

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Immunosuppressive Agents

Share to Multiple Sclerosis

Share to Pyridines

Share to T-Lymphocyte Subsets

Share to T-Lymphocytes

Source

Identifiers

PMID: 28686480
DOI: 10.1080/08916934.2017.1332185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Caerulomycin A suppresses the differentiation of naïve T cells and alleviates the symptoms of experimental autoimmune encephalomyelitis.PMID 28686480Read ↗

Role of Immune Cells in Multiple Sclerosis and Experimental Autoimmune EncephalomyelitisSemantic proximity Read ↗

Cordycepin Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Infiltration and Reducing NeuroinflammationSemantic proximity Read ↗

Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal ModelsSemantic proximity Read ↗

Experimental Autoimmune Encephalomyelitis Mediated by CD8<sup>+</sup> T CellsSemantic proximity Read ↗

Targeted Therapy of Multiple Sclerosis: a Case for Antigen-specific TregsSemantic proximity Read ↗

CD8+ T-Cells as Immune Regulators of Multiple SclerosisSemantic proximity Read ↗

Targeted Modulation of Inflammatory Lymphocytes and Neurogenesis/Neuroprotection Associated Genes by Curcumin and a Novel Derivative of Curcumin on Mice Experimental Autoimmune Encephalomyelitis ModelSemantic proximity Read ↗

Pathogenic mechanisms and experimental models of multiple sclerosis.Semantic proximity Read ↗

Radiolabeled dendrimer non-invasively tracks innate immune activation in multiple sclerosis mice after immunomodulatory therapySemantic proximity Read ↗

Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis.Semantic proximity Read ↗

CD8<sup>+</sup>T cells in multiple sclerosisSemantic proximity Read ↗

Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.